![]() |
| • |
Revenue of $760 million, a 4% increase compared to the prior quarter and a 3% increase compared to the prior year
|
| • |
Loss from operations of $41 million; Net loss attributable to Tronox of $103 million including $15 million of restructuring and other charges, net of taxes, primarily associated with the closure of the
Company’s Botlek and Fuzhou pigment plants; Adjusted net loss attributable to Tronox was $88 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $0.65; Adjusted diluted loss per share was $0.55 (non-GAAP)
|
| • |
Adjusted EBITDA of $62 million; Adjusted EBITDA margin of 8.2% (non-GAAP)
|
| • |
Capital expenditures of $67 million in the quarter
|
| • |
Expect free cash flow to be positive in Q2 2026, largely offsetting Q1 cash use; Expect to deliver meaningful positive free cash flow for full year
2026
|
| • |
Expect Q2 2026 TiO2 volumes to increase sequentially in the high single-digit percentage range
|
| • |
Expect Q2 2026 zircon volume levels to moderate slightly compared to Q1
|
| • |
TiO2 and zircon Q2 2026 volumes could be higher, depending on regional inventory availability
|
| • |
TiO2 and zircon pricing both expected to improve sequentially in the mid-single-digit percentage range in Q2 2026 as a result of
announced price increases and cost input-related surcharges
|
| • |
Q2 2026 Adjusted EBITDA expected to be $65-$85 million
|
|
($M unless otherwise noted)
|
Q1 2026
|
Q1 2025
|
Y-o-Y%∆
|
|
Q4 2025
|
Q-o-Q%∆
|
|
|||||||||||||
|
Revenue
|
$
|
760
|
$
|
738
|
3
|
%
|
$
|
730
|
4
|
%
|
||||||||||
|
TiO2
|
$
|
616
|
$
|
584
|
5
|
%
|
$
|
577
|
7
|
%
|
||||||||||
|
Zircon
|
$
|
89
|
$
|
69
|
29
|
%
|
$
|
78
|
14
|
%
|
||||||||||
|
Other products
|
$
|
55
|
$
|
85
|
(35
|
)%
|
$
|
75
|
(27
|
)%
|
||||||||||
|
(Loss) from operations
|
$
|
(41
|
)
|
$
|
(61
|
)
|
n/
|
m
|
$
|
(114
|
)
|
n/
|
m
|
|||||||
|
Net (loss) attributable to Tronox
|
$
|
(103
|
)
|
$
|
(111
|
)
|
n/
|
m
|
$
|
(176
|
)
|
n/
|
m
|
|||||||
|
GAAP diluted (loss) per share
|
$
|
(0.65
|
)
|
$
|
(0.70
|
)
|
n/
|
m
|
$
|
(1.11
|
)
|
n/
|
m
|
|||||||
|
Adjusted diluted (loss) per share
|
$
|
(0.55
|
)
|
$
|
(0.15
|
)
|
n/
|
m
|
$
|
(0.60
|
)
|
n/
|
m
|
|||||||
|
Adjusted EBITDA
|
$
|
62
|
$
|
112
|
(45
|
)%
|
$
|
57
|
9
|
%
|
||||||||||
|
Adjusted EBITDA Margin %
|
8.2
|
%
|
15.2
|
%
|
(700
|
)bps |
7.8
|
%
|
40
|
bps | ||||||||||
|
Free cash flow
|
$
|
(135
|
)
|
$
|
(142
|
)
|
n/
|
m
|
$
|
53
|
n/
|
m | ||||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
5 %
|
(4)%
|
4 %
|
4 %
|
3 %
|
0 %
|
|
Zircon
|
57 %
|
(28)%
|
— %
|
14 %
|
0 %
|
— %
|
|
Three Months Ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net sales
|
$
|
760
|
$
|
738
|
||||
|
Cost of goods sold
|
716
|
639
|
||||||
|
Gross profit
|
44
|
99
|
||||||
|
Restructuring and other charges
|
14
|
86
|
||||||
|
Selling, general and administrative expenses
|
71
|
74
|
||||||
|
Loss from operations
|
(41
|
)
|
(61
|
)
|
||||
|
Interest expense
|
(53
|
)
|
(42
|
)
|
||||
|
Interest income
|
2
|
2
|
||||||
|
Loss on extinguishment of debt
|
—
|
—
|
||||||
|
Other expense, net
|
(12
|
)
|
(5
|
)
|
||||
|
Loss before income taxes
|
(104
|
)
|
(106
|
)
|
||||
|
Income tax provision
|
—
|
(5
|
)
|
|||||
|
Net loss
|
(104
|
)
|
(111
|
)
|
||||
|
Net loss attributable to noncontrolling interest
|
(1
|
)
|
—
|
|||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(103
|
)
|
$
|
(111
|
)
|
||
|
Loss per share:
|
||||||||
|
Basic
|
$
|
(0.65
|
)
|
$
|
(0.70
|
)
|
||
|
Diluted
|
$
|
(0.65
|
)
|
$
|
(0.70
|
)
|
||
|
Weighted average shares outstanding, basic (in thousands)
|
158,889
|
158,138
|
||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,889
|
158,138
|
||||||
| Other Operating Data: |
||||||||
| Capital expenditures |
67 |
110 |
||||||
| Depreciation, depletion and amortization
expense |
75 |
71 |
||||||
|
Three Months Ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(103
|
)
|
$
|
(111
|
)
|
||
|
Restructuring and other charges (a)
|
14
|
86
|
||||||
|
Other (b)
|
1
|
1
|
||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(88
|
)
|
$
|
(24
|
)
|
||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(0.65
|
)
|
$
|
(0.70
|
)
|
||
|
Restructuring and other charges, per share
|
0.09
|
0.54
|
||||||
|
Other, per share
|
0.01
|
0.01
|
||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$ |
(0.55 |
) |
$ |
(0.15
|
) |
||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,889
|
158,138
|
||||||
|
|
March 31, 2026
|
December 31, 2025
|
||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
126
|
$
|
199
|
||||
|
Restricted cash
|
12
|
12
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of March 31, 2026 and December 31, 2025,
respectively)
|
331
|
289
|
||||||
|
Inventories, net
|
1,577
|
1,652
|
||||||
|
Prepaid and other assets
|
119
|
112
|
||||||
|
Income taxes receivable
|
1
|
1
|
||||||
|
Total current assets
|
2,166
|
2,265
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,973
|
2,007
|
||||||
|
Mineral leaseholds, net
|
594
|
608
|
||||||
|
Intangible assets, net
|
208
|
214
|
||||||
|
Lease right of use assets, net
|
169
|
173
|
||||||
|
Deferred tax assets
|
834
|
833
|
||||||
|
Other long-term assets
|
113
|
117
|
||||||
|
Total assets
|
$
|
6,057
|
$
|
6,217
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
419
|
$
|
481
|
||||
|
Accrued liabilities
|
231
|
274
|
||||||
|
Short-term lease liabilities
|
22
|
22
|
||||||
|
Obligations under inventory financing arrangement
|
50
|
50
|
||||||
|
Short-term debt
|
133
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
Income taxes payable
|
1
|
2
|
||||||
|
Total current liabilities
|
895
|
919
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,124
|
3,132
|
||||||
|
Pension and postretirement healthcare benefits
|
80
|
81
|
||||||
|
Asset retirement obligations
|
207
|
198
|
||||||
|
Environmental liabilities
|
39
|
39
|
||||||
|
Long-term lease liabilities
|
146
|
148
|
||||||
|
Deferred tax liabilities
|
204
|
208
|
||||||
|
Other long-term liabilities
|
41
|
43
|
||||||
|
Total liabilities
|
4,736
|
4,768
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 159,518,772 shares issued and outstanding at March 31, 2026 and
158,557,858 shares issued and outstanding at December 31, 2025
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,101
|
2,103
|
||||||
|
(Accumulated deficit) retained earnings
|
(73
|
)
|
30
|
|||||
|
Accumulated other comprehensive loss
|
(741
|
)
|
(717
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,289
|
1,418
|
||||||
|
Noncontrolling interest
|
32
|
31
|
||||||
|
Total equity
|
1,321
|
1,449
|
||||||
|
Total liabilities and equity
|
$
|
6,057
|
$
|
6,217
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(104
|
)
|
$
|
(111
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
75
|
71
|
||||||
|
Deferred income taxes
|
-
|
4
|
||||||
|
Share-based compensation expense
|
6
|
5
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
3
|
2
|
||||||
|
Restructuring and other charges
|
14
|
86
|
||||||
|
Other non-cash items affecting net loss
|
16
|
12
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(43
|
)
|
(49
|
)
|
||||
|
Decrease (increase) in inventories, net
|
67
|
(35
|
)
|
|||||
|
Decrease in prepaid and other assets
|
5
|
18
|
||||||
|
Restructuring payments
|
(19
|
)
|
(2
|
)
|
||||
|
Decrease in accounts payable and accrued liabilities
|
(80
|
)
|
(22
|
)
|
||||
|
Net changes in income tax payables and receivables
|
-
|
(4
|
)
|
|||||
|
Changes in other non-current assets and liabilities
|
(8
|
)
|
(7
|
)
|
||||
|
Cash used in operating activities
|
(68
|
)
|
(32
|
)
|
||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(67
|
)
|
(110
|
)
|
||||
|
Loans
|
-
|
15
|
||||||
|
Cash used in investing activities
|
(67
|
)
|
(95
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(97
|
)
|
(6
|
)
|
||||
|
Repayments of long-term debt
|
(8
|
)
|
(6
|
)
|
||||
|
Repayments of inventory financing arrangement
|
(50
|
)
|
-
|
|||||
|
Proceeds from short-term debt
|
182
|
121
|
||||||
|
Proceeds from inventory financing arrangement
|
50
|
-
|
||||||
|
Debt issuance costs
|
(2
|
)
|
-
|
|||||
|
Dividends paid
|
(8
|
)
|
-
|
|||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(1
|
)
|
|||||
|
Cash provided by financing activities
|
67
|
108
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(5
|
)
|
5
|
|||||
|
Net decrease in cash and cash equivalents and restricted cash
|
(73
|
)
|
(14
|
)
|
||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
211
|
152
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
138
|
$
|
138
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net loss (U.S. GAAP)
|
$
|
(104
|
)
|
$
|
(111
|
)
|
||
|
Interest expense
|
53
|
42
|
||||||
|
Interest income
|
(2
|
)
|
(2
|
)
|
||||
|
Income tax provision
|
—
|
5
|
||||||
|
Depreciation, depletion and amortization expense
|
75
|
71
|
||||||
|
EBITDA (non-U.S. GAAP)
|
22
|
5
|
||||||
|
Share-based compensation (a)
|
6
|
5
|
||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b)
|
4
|
7
|
||||||
|
Accounts receivable securitization program (c)
|
3
|
4
|
||||||
|
Foreign currency remeasurement (d)
|
7
|
1
|
||||||
|
Restructuring and other charges (e)
|
14
|
86
|
||||||
|
Other items (f)
|
6
|
4
|
||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
62
|
$
|
112
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
Net sales
|
$
|
760
|
$
|
738
|
||||
|
Net loss (U.S. GAAP)
|
$
|
(104
|
)
|
$
|
(111
|
)
|
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(13.7
|
)%
|
(15.0
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
8.2
|
%
|
15.2
|
%
|
||||
|
March 31, 2026
|
December 31, 2025
|
|||||||
|
Long-term debt, net
|
$
|
3,124
|
$
|
3,132
|
||||
|
Short-term debt
|
133
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
(Less) Cash and cash equivalents
|
(126
|
)
|
(199
|
)
|
||||
|
Net debt
|
$
|
3,170
|
$
|
3,023
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
286
|
$
|
336
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
11.1
|
x
|
9.0
|
x
|
||||
|
Three Months Ended
March 31, 2026
|
||||
|
Cash used in operating activities
|
$
|
(68
|
)
|
|
|
Capital expenditures
|
(67
|
)
|
||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(135
|
)
|
|
|
Three Months Ended
|
Trailing Twelve Month
Adjusted EBITDA
|
|||||||||||||||||||
|
June 30, 2025
|
September 30, 2025
|
December 31, 2025
|
March 31, 2026
|
|||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(85
|
)
|
$
|
(100
|
)
|
$
|
(177
|
)
|
$
|
(104
|
)
|
$
|
(466
|
)
|
|||||
|
Interest expense
|
45
|
48
|
54
|
53
|
200
|
|||||||||||||||
|
Interest income
|
(1
|
)
|
(1
|
)
|
(2
|
)
|
(2
|
)
|
(6
|
)
|
||||||||||
|
Income tax provision
|
4
|
8
|
(2
|
)
|
—
|
10
|
||||||||||||||
|
Depreciation, depletion and amortization expense
|
74
|
75
|
82
|
75
|
306
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
37
|
30
|
(45
|
)
|
22
|
44
|
||||||||||||||
|
Share-based compensation (a)
|
4
|
5
|
6
|
6
|
21
|
|||||||||||||||
|
Foreign currency remeasurement (b)
|
(2
|
)
|
—
|
7
|
7
|
12
|
||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
7
|
6
|
(11
|
)
|
4
|
6
|
||||||||||||||
|
Accounts receivable securitization program (d)
|
3
|
3
|
3
|
3
|
12
|
|||||||||||||||
|
Restructuring and other charges (e)
|
42
|
25
|
79
|
14
|
160
|
|||||||||||||||
|
Other items (f)
|
2
|
5
|
18
|
6
|
31
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
93
|
$
|
74
|
$
|
57
|
$
|
62
|
$
|
286
|
||||||||||
|
15 | Page
|